Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study
- PMID: 25654626
- DOI: 10.1089/jwh.2014.5000
Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study
Abstract
Background: Polycystic ovary syndrome (PCOS) affects 6%-21% of women. PCOS is the primary cause of anovulatory infertility, with major health and economic costs, yet we are unaware of any community-based, natural history studies on fertility and fertility treatments published to date. We aim to compare infertility, fertility treatment use, and relationship to body mass index (BMI) in women reporting PCOS to women not reporting PCOS in a community-based population.
Methods: This is a cross-sectional analysis of a longitudinal cohort study, the Australian Longitudinal Study on Women's Health (ALSWH). For the ALSWH, women from the general community were randomly selected from the national public insurance database. Mailed survey data were collected at multiple time points. At survey 4, there were 9145 respondents aged 28-33 years. Of 8612 women with known PCOS status, 478 women reported having PCOS. Information regarding fertility status was available for 4856 women. This was the subgroup used in this analysis. The main outcomes measures are self-reported PCOS status, BMI, infertility, and use of fertility therapies including ovulation induction and in vitro fertilization (IVF). Logistic regression was used to examine factors associated with infertility and use of fertility treatment.
Results: Self-reported PCOS prevalence was 5.8% (95% confidence interval [CI]: 5.3%-6.4%). Infertility was noted by 72% of 309 women reporting PCOS, compared with 16% of 4547 women not reporting PCOS (p<0.001). Infertility was 15-fold higher in women reporting PCOS (adjusted odds ratio 14.9, 95% CI 10.9-20.3), independent of BMI. Of women reporting infertility, there was greater use of fertility hormone treatment, (62%, n=116 vs. 33%, n=162, p<0.001) in women reporting PCOS; however, IVF use was similar.
Conclusions: In this community-based cohort of women, infertility and use of fertility hormone treatment was significantly higher in women reporting PCOS. Considering the prevalence of PCOS and the health and economic burden of infertility, strategies to optimize fertility are important.
Similar articles
-
Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With Obesity.Am J Hypertens. 2015 Jul;28(7):847-51. doi: 10.1093/ajh/hpu251. Epub 2014 Dec 26. Am J Hypertens. 2015. PMID: 25542625
-
Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women.Obesity (Silver Spring). 2013 Aug;21(8):1526-32. doi: 10.1002/oby.20213. Epub 2013 Jul 2. Obesity (Silver Spring). 2013. PMID: 23818329
-
Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health.Hum Reprod. 2014 Apr;29(4):802-8. doi: 10.1093/humrep/deu020. Epub 2014 Feb 18. Hum Reprod. 2014. PMID: 24549213
-
Infertility and pregnancy in women with polycystic ovary syndrome.Minerva Endocrinol. 2010 Dec;35(4):211-25. Minerva Endocrinol. 2010. PMID: 21178917 Review.
-
The treatment of infertility in polycystic ovary syndrome: a brief update.Aust N Z J Obstet Gynaecol. 2012 Aug;52(4):400-3. doi: 10.1111/j.1479-828X.2012.01448.x. Epub 2012 May 28. Aust N Z J Obstet Gynaecol. 2012. PMID: 22639834 Review.
Cited by
-
The effect of vitamin D supplementation on markers of insulin resistance in women with polycystic ovarian syndrome: a systematic review.Eur J Nutr. 2024 Dec;63(8):2859-2869. doi: 10.1007/s00394-024-03489-6. Epub 2024 Sep 14. Eur J Nutr. 2024. PMID: 39276209 Free PMC article. Review.
-
Ovarian ferroptosis induced by androgen is involved in pathogenesis of PCOS.Hum Reprod Open. 2024 Feb 28;2024(2):hoae013. doi: 10.1093/hropen/hoae013. eCollection 2024. Hum Reprod Open. 2024. PMID: 38550897 Free PMC article.
-
Efficacy of Letrozole vs Clomiphene Citrate for induction of ovulation in women with polycystic ovarian syndrome.Pak J Med Sci. 2024 Jan-Feb;40(1Part-I):78-83. doi: 10.12669/pjms.40.1.7971. Pak J Med Sci. 2024. PMID: 38196458 Free PMC article.
-
The Effect of Normal Follicular Fluid on the Differentiation of PCOS Ovarian Stem Cells into Oocyte-Like Cells.Adv Biomed Res. 2023 Nov 29;12:259. doi: 10.4103/abr.abr_151_23. eCollection 2023. Adv Biomed Res. 2023. PMID: 38192893 Free PMC article.
-
Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.BMC Complement Med Ther. 2023 Dec 15;23(1):458. doi: 10.1186/s12906-023-04280-6. BMC Complement Med Ther. 2023. PMID: 38102584 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical